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INTRODUCTION {#jso23941-sec-0005}
============

Lung Cancer continues to have high morbidity and mortality, and it is estimated that in 2014 in the United States there were approximately 224,210 new cases and 159,260 deaths from lung cancer, accounting for about 27% of all cancer deaths [1](#jso23941-bib-0001){ref-type="ref"}, [2](#jso23941-bib-0002){ref-type="ref"}. The National Lung Screening Trial demonstrated that screening for lung cancer with chest computed tomography (CT) results in a 20% reduction in mortality [3](#jso23941-bib-0003){ref-type="ref"}, [4](#jso23941-bib-0004){ref-type="ref"}, [5](#jso23941-bib-0005){ref-type="ref"}. However, most nodules detected by CT were not cancer but required interval follow‐up and/or biopsies for definitive diagnosis, translating to a large and technically challenging diagnostic burden. Proposed criteria (Early Lung Cancer Action Project) recommend biopsy and/or surgical resection for nodules larger than 1 cm and follow‐up with CT scans for smaller lesions to demonstrate stability [4](#jso23941-bib-0004){ref-type="ref"}, [6](#jso23941-bib-0006){ref-type="ref"}, [7](#jso23941-bib-0007){ref-type="ref"}.

In view of the recent United States Preventative Services Task Force category B recommendations for Lung Cancer Screening (LCS), it is expected that many patients with small lesions (\<2 cm), enlarging lesions, and partially solid lesions that are suspicious for cancer will be discovered and will require surgical resection [5](#jso23941-bib-0005){ref-type="ref"}, [8](#jso23941-bib-0008){ref-type="ref"}, [9](#jso23941-bib-0009){ref-type="ref"}. The difficulty in locating, palpating, and obtaining an accurate biopsy of small nodules was the rationale for designing a clinical trial with the goal of resecting early peripheral lung cancers with minimally invasive surgery. The sensitivity of cancer diagnosis using percutaneous, image‐guided biopsy decreases with decreasing nodule size (e.g. 90% for 3 cm diameter versus 70% for 1 cm) and is substantially less accurate for Ground Glass Opacities (GGOs). Thus, patients with suspicious or enlarging lesions are often referred for surgical excision. However, the scope and extent of surgical resection depends on the ability to localize nodules, especially deep and lesions difficult to palpate. Intraoperative localization of these lesions can be challenging and can depend on factors such as size of the lesion, depth from the pleural surface, and size of the solid component [10](#jso23941-bib-0010){ref-type="ref"}.

Several techniques have been previously reported to assist in localizing peripheral lung lesions prior to resection, including the use of intraoperative transthoracic ultrasonography, percutaneous injection of dye (lipiodol, cyanoacrylate, "colored" collagen, barium sulphate, and methylene blue), image‐guided placement of microcoils, spring hook wires, and Kopans wire hooks [11](#jso23941-bib-0011){ref-type="ref"}, [12](#jso23941-bib-0012){ref-type="ref"}. These multidisciplinary approaches, involving image‐guided placement of radiopaque or visual markers prior to the patient being moved to the operating room, have proven to be very helpful, however they are associated with the risks for contamination, marker migration, and lung injury while transporting the patient from the CT suite to the operating room. The optimal strategy would be to provide the ability to place markers using image guidance in the hybrid OR, immediately prior to resection, with the patient already in the surgical position with lung isolation established during a single anesthetic.

Our aim was to develop high‐precision interventions by improving current surgical and diagnostic techniques using intraoperative image guidance to facilitate successful lesion identification and resection. The primary objective of the clinical trial reported herein was establishing a safe and optimal procedural workflow for combining image‐guidance with immediate surgery. The secondary objectives were to determine the peri‐operative outcomes including successful nodule localization and to complete excision of the nodule.

METHODS {#jso23941-sec-0006}
=======

With approval from Institutional Review Board ([ClinicalTrials.gov](http://ClinicalTrials.gov) *number NCT01847209)*, we prospectively enrolled subjects with small pulmonary nodules suspicious for malignancy who were referred for surgery at a single academic medical center.

Patient Selection {#jso23941-sec-0007}
-----------------

The study cohort included patients suitable for VATS lung wedge resection due to limited lung function, prior lobectomy, small nodules, multiple bilateral nodules, and/or patient preference. Lesions included solid, partially solid, and ground glass opacities (GGOs) measuring ≤ 30 mm in diameter on preoperative evaluation of CT imaging. All patients were older than 18 years of age.

iVATS (IMAGE GUIDED VIDEO ASSISTED THORACOSCOPIC SURGERY) {#jso23941-sec-0008}
=========================================================

Lesion Localization {#jso23941-sec-0009}
-------------------

Pre‐operative CT scans were used to generate three‐dimensional surface models for surgical planning (Fig. [1](#jso23941-fig-0001){ref-type="fig"}A, B). The images were reviewed by the team to determine optimal placement of fiducials. Patients were brought into the Advanced Multimodality Image Guided Operating (AMIGO) Room, general anesthesia was administered, bronchoscopic examination performed, a double‐lumen endo‐bronchial tube was positioned, and patients were placed in the lateral decubitus position. A C‐arm CT scan of the pre‐determined field of view that included the nodule position was acquired during an end‐inspiratoryhold maneuver using a 5 sec scan protocol with 0.36 μGy/projection and 248 projections acquired over 200°. The radiologist reviewed the C‐arm CT scan to localize the nodule and plan trajectories for percutaneous T‐bar placement using *Syngo* iGuide needle guidance software (Siemens Healthcare AG, Forchheim, Germany) (Fig. [1](#jso23941-fig-0001){ref-type="fig"}C). The planned needle pathways were integrated into the C‐arm fluoroscopic imaging system, which provided laser crosshair and guidance markers on fluoroscopy images to direct the needle pathway for T‐bar placement (Kimberly‐Clark, Roswell, GA) (Fig. [1](#jso23941-fig-0001){ref-type="fig"}E, F).

![(**a**) Pre‐operative axial CT image depicting a 6mm solid right lower lobe nodule. (**b**) 3D volume rendered image showing the relationship of the nodule to the bones. (**c**) i‐Guide pathway planning on sagittal C‐arm CT image. (**d**) T‐bar (fiducial). (**e**) Placement of the fiducials under fluoroscopic guidance using i‐Guide. (**f**) Fluoroscopy image after deployment of the fiducials around the target. (**g**) Intra‐operative image showing the fiducial wires extending to the chest wall from the collapsed lung. (**h**) Resected lung specimen with both wires extending through the lung.](JSO-112-18-g001){#jso23941-fig-0001}

Surgery {#jso23941-sec-0010}
-------

Patients were prepped and draped for VATS, and a wedge resection was performed with guidance and thoracoscopic visualization of the T‐bar sutures (Fig. [1](#jso23941-fig-0001){ref-type="fig"}G). Lymphadenectomy or lymph node sampling was routinely performed. The specimen and T‐bars were removed using an endo‐bag. CT scan of the excised lung wedge (Fig. [1](#jso23941-fig-0001){ref-type="fig"}H) was acquired in an adjoining room to ensure complete excision of the T‐bars and nodule. Frozen section histological analysis provided the diagnosis and confirmed negative margins of resection. All incisions were closed, the chest was drained and the patient awoken, extubated, and transferred to recovery. (Video 1)

Study Objectives {#jso23941-sec-0011}
----------------

The primary objective of the study was to establish safe and optimal procedural workflow. The secondary objectives were to determine the peri‐operative outcomes including successful nodule localization via placed T‐bar fiducials and to complete excision of the nodule and optimization of radiation dose for the procedure.

RESULTS {#jso23941-sec-0012}
=======

Twenty‐five eligible patients were enrolled in this study, and 23 patients had successful resection of their pulmonary nodules. One patient withdrew from the trial prior to surgery, and one patient was found to have complete resolution of the nodule on the intra‐operative CT scan.

Of the 23 patients who underwent surgery, seven were men and 16 were women with a median age of 65 years (Table [I](#jso23941-tbl-0001){ref-type="table-wrap"}). Most patients were current or former cigarette smokers. In accordance with the trial\'s eligibility criteria, the indication for the VATS wedge resection versus lobectomy in each of these patients was the small nodule size, prior lobectomy, limited lung function, expectation for future contralateral lung resection, or patient preference. By preoperative CT scan evaluation, 15 of the nodules were either GGOs or partially solid. The median nodule size by preoperative CT scan was 1.3 cm. (Fig. [2](#jso23941-fig-0002){ref-type="fig"}) of the 22 cancers, 18 were primary lung cancers and four were metastatic lesions. Seven of the primary malignant nodules were minimally invasive adenocarcinoma with some degree of invasive component and one nodule was adenocarcinoma in situ. All of the resected lung cancers were partially solid or mixed ground glass lesions, and the adenocarcinoma in situ was pure ground glass attenuation.

###### 

Patient Characteristics (N = 23)

  -------------------------------------------------------------------------------- --------
  Gender (N)                                                                       
  Male                                                                             7
  Female                                                                           16
  Age                                                                              
  Median                                                                           65
  Range                                                                            19--80
  Comorbidities                                                                    
  Pulmonary[^a^](#jso23941-note-0002){ref-type="fn"}                               6
  COPD[^b^](#jso23941-note-0003){ref-type="fn"}                                    5
  Pulmonary hypertension[^b^](#jso23941-note-0003){ref-type="fn"}                  1
  Cardiac[^a^](#jso23941-note-0002){ref-type="fn"}                                 3
  Non‐ischemic cardiomyopathy[^b^](#jso23941-note-0003){ref-type="fn"}             1
  CAD[^b^](#jso23941-note-0003){ref-type="fn"}                                     1
  CHF[^b^](#jso23941-note-0003){ref-type="fn"}                                     1
  Prior cancer history[^a^](#jso23941-note-0002){ref-type="fn"}                    11
  Squamous cell carcinoma of the tongue[^b^](#jso23941-note-0003){ref-type="fn"}   1
  Prostate cancer[^b^](#jso23941-note-0003){ref-type="fn"}                         2
  Renal cell carcinoma[^b^](#jso23941-note-0003){ref-type="fn"}                    1
  Breast cancer[^b^](#jso23941-note-0003){ref-type="fn"}                           5
  Lung cancer[^b^](#jso23941-note-0003){ref-type="fn"}                             4
  Hodgkin\'s lymphoma[^b^](#jso23941-note-0003){ref-type="fn"}                     1
  Endometrial cancer[^b^](#jso23941-note-0003){ref-type="fn"}                      1
  Smoking History (N)                                                              
  ≥30 pack‐years                                                                   9
  (Quit \>15 years ago)                                                            \(5\)
  \<30 pack‐years                                                                  6
  Pack‐years unknown, not current smokers                                          2
  Never smokers                                                                    6
  -------------------------------------------------------------------------------- --------

COPD, Chronic Obstructive Pulmonary Disease; CAD, Coronary Artery Disease; CHF, Congestive Heart Failure.

Number of Patients.

Number of Cases.
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![(**a**) Solid right upper lobe nodule in a patient with breast cancer and sarcoma, found to be consistent with a sarcoma metastasis. (**b**) Right lower lobe part solid nodule, on frozen section found to have micropapillary feature, prompting a decision for completion lobectomy. (**c**) Right upper lobe part solid lesion biopsy, was found to be consistent with lung cancer. (**d**) Right upper lobe part solid lesion with progressive growth, final pathology consistent with a granuloma. (**e**) Part solid lesion in the left lower lobe stable on two scans 3 months apart, but resolved on the day of the surgery.](JSO-112-18-g002){#jso23941-fig-0002}

Study Outcomes {#jso23941-sec-0013}
--------------

Twenty‐three of 24 nodules were identified by intra‐operative C‐ arm CT scan and completely resected by VATS. The patient whose nodule had resolved had a follow up CT scan 6 months later with confirmation of complete resolution. Twenty patients (87.0%) had successful intra‐operative fluoroscopy‐guided placement of two flanking T‐bars to localize the small pulmonary nodule. The sutures attached to the two T‐bars placed around the lesions in these patients were visible on the pleural surface of the lung at thoracoscopy. Three patients underwent successful T‐bar placement, but at thoracoscopy both T‐bars were dislodged in one patient and one of the two T‐bars was dislodged in two patients. Though the T‐bars were dislodged from the lung parenchyma, all three nodules were completely excised utilizing the information from the planning C‐arm CT scan and entry marks of the needle into the lung. One patient required a completion lobectomy at the time of surgery because of micropapillary features found in the lesion during frozen pathology analysis of the wedge resection.

Median length of time for completion of each case measured from when the patient was brought into the operating room to when the patient was taken to recovery was 212 (range 144--297) min. Median duration from anesthesia induction to the first VATS incision was 130 (range 82--238) min (Table [II](#jso23941-tbl-0002){ref-type="table-wrap"}). This period measures the time required for taking the intra‐operative C‐arm CT scan, calculating the trajectory and placing the T‐bars. The median lengths of time required for placement of the two T‐bars and for the VATS ("skin to skin") were 39 (range 23--62) and 67 (38--156) min, respectively. The median radiation exposure from the intra‐operative C‐arm CT scan and fluoroscopy was 1501 μGy\*m^2^ (range 665--16326). The dosimeter was non‐functional during part of one procedure, and thus only the radiation exposure from the C‐arm CT scan was recorded for this procedure.

###### 

Operative Time Course and Radiation Exposure From Intra‐Operative CT and Fluoroscopy (Patients 6 and 22 did not Undergo Surgery)

  Patient (N = 23)   Induction to incision time (min)   Placement of first T‐bar to incision time (min)   Incision to close time (min)   Radiation exposure (mSv)
  ------------------ ---------------------------------- ------------------------------------------------- ------------------------------ --------------------------
  1                  135                                35                                                62                             36.5
  2                  150                                23                                                72                             17.5
  3                  131                                41                                                84                             3.5
  4                  119                                36                                                156                            5.1
  5                  141                                26                                                105                            2.6
  7                  142                                52                                                83                             8.8
  8                  136                                39                                                116                            3.1
  9                  132                                36                                                65                             6.3
  10                 158                                48                                                58                             4.1
  11                 111                                41                                                100                            4.1
  12                 99                                 41                                                55                             2.8
  13                 142                                43                                                76                             2.3
  14                 108                                33                                                59                             4.0
  15                 130                                37                                                50                             2.7
  16                 124                                40                                                67                             2.2
  17                 88                                 36                                                90                             5.0
  18                 82                                 34                                                79                             2.8
  19                 140                                62                                                54                             3.6
  20                 122                                42                                                63                             4.7
  21                 116                                51                                                100                            6.3
  23                 238                                29                                                40                             3.1
  24                 118                                52                                                38                             3.3
  25                 91                                 30                                                40                             3.2

© 2015 Wiley Periodicals, Inc.

The visible T‐bar sutures at the pleural surface of the wedge resection specimen as well as the postoperative CT scan of the resected lung confirmed the presence of the T‐bars in the lung wedge. Pathologic analysis confirmed the presence of the resected tumor and the T‐bars as well as adequacy of the margins of resection. In two patients, pneumothoraces occurred during the placement of the second T‐bars, but there was no associated hemodynamic compromise and no treatment was warranted, as the patients were about to undergo VATS with subsequent chest tube placements. All T‐bars were recovered.

Twenty‐two of the resected nodules demonstrated malignancies while one nodule was a benign granuloma (Table [III](#jso23941-tbl-0003){ref-type="table-wrap"}).

###### 

Radiological and Pathological Characteristics of the Resected Pulmonary Nodules

  Patient (N = 23)   Size of lesion in (cm) on pre‐operative CT scan   Actual size of lung nodule (Pathological)   Location of lesion   Associated or ancillary findings                                                     CT appearance of the nodule and diagnosis based on history and imaging                                                                        Final pathological diagnosis
  ------------------ ------------------------------------------------- ------------------------------------------- -------------------- ------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------
  1                  2.0 and 1.2                                       2.0, 1.2 (two foci)                         Right upper lobe     Three less than 5 mm pure ground glass opacities in left upper lobe                  Dominant part solid nodule and adjacent part solid lesions concerning for adenocarcinoma                                                      Moderately differentiated Lung Adenocarcinoma pT3 N0
  2                  1.7                                               2.0                                         Right upper lobe     Evidence of Pulmonary Hypertension                                                   Increase in size of pure ground glass opacity over 3 years concerning for malignancy                                                          Granuloma
  3                  0.8                                               0.8 0.3 cm invasive component               Left upper lobe      2 pack/year smoking history for 15 years                                             Part solid lesion with central 3mm solid component concerning for MIA                                                                         Minimally Invasive Lung Adenocarcinoma pT1aN0
  4                  1.6                                               1.2                                         Right Lower lobe     1 pack /year smoking history for 20 years                                            Part solid lesion with increase in solid component over 2 years concerning for invasive adenocarcinoma                                        Moderately differentiated lung adenocarcinoma with micropapillary features pTa1N0
  5                  1.4                                               1.3                                         Right upper lobe     Past history of T1N0 Tongue cancer, moderate centrilobular emphysema                 Spiculated solid nodule could represent metastasis or new Lung primary                                                                        Metastatic Tongue Squamous Cell Carcinoma
  7                  1.8                                               2.1                                         Left upper lobe      37 pack/year smoking history                                                         Part solid lesion with increase in solid component over 2 years concerning for adenocarcinoma                                                 Moderately differentiated lung adenocarcinoma acinar predominant pT1bN0
  8                  1.7                                               1.9                                         Right upper lobe     History breast cancer                                                                Pure ground glass opacity stable over 1 year biopsy concerning for lung cancer                                                                Lung Adenocarcinoma acinar (70%) and lepidic (30%) pattern pT1aN0
  9                  1.2                                               1.5                                         Right upper lobe     History renal cell carcinoma with prior resection in the lung for renal metastases   Solid right upper lobe nodule increased in size over 6 months                                                                                 Metastatic Renal Cell Carcinoma
  10                 0.9                                               0.8                                         Right lower lobe     Cushing\'s disease                                                                   Solid, oblong nodule could represent a functioning carcinoid                                                                                  Carcinoid pT1a Nx
  11                 0.6                                               1.1 0.4 cm invasive component               Right upper lobe     Former smoker, upper lobe predominant emphysema                                      Part solid lesion concerning for MIA stable over 6 months                                                                                     Minimally Invasive Lung Adenocarcinoma pT1aN0
  12                 1.2                                               1.4                                         Right upper lobe     1.5--2 pack/year for 17 years, severe upper lobe predominant emphysema               Slow growing part solid lesion concerning for adenocarcinoma                                                                                  Well‐differentiated lung adenocarcinoma acinar (10%) and lepidic (90%) pT1aN0
  13                 1.4                                               2.5                                         Right lower lobe     Previous right upper lobectomy, with multiple ground glass opacities                 Part solid right lower lobe lesion growing over 6 months concerning for MIA                                                                   Moderately differentiated lung adenocarcinoma acinar, lepidic and solid
  14                 1.3                                               1.2                                         Right lower lobe     Incidentally found lung nodule on a CT angiogram for aortic aneurysm                 Well defined solid nodule could represent a carcinoid or lung cancer                                                                          Carcinoid pT1a Nx
  15                 1.6                                               1.2 0.4 cm invasive component               Right lower lobe     Previous resection of left Lung cancer and known multiple ground glass opacities     Multiple ground glass opacities with increase in size of solid component of the right lower lobe lesion concerning for MIA                    Minimally Invasive Lung Adenocarcinoma pT1aN0
  16                 1.3                                               1.0 0.4 cm invasive component               Left upper lobe      Past smoker and cardiac history                                                      Part solid lesion concerning for MIA                                                                                                          Minimally Invasive Lung Adenocarcinoma pT1aN0
  17                 0.8                                               1.5                                         Left upper lobe      Past history of right lung cancer                                                    Part solid lesion could represent metastasis or new primary lung cancer                                                                       Lung Adenocarcinoma
  18                 1.4                                               1.0 (0.2 cm invasive component)             Right upper lobe     Multiple ground glass opacities                                                      Increase in size of the dominant part solid right upper lobe lesion concerning for MIA in the setting of multifocal adenomatous hyperplasia   Minimally Invasive Lung Adenocarcinoma pT1aN0
  19                 0.7                                               0.7, 0.5 (two foci)                         Right upper lobe     History of breast cancer and sarcoma                                                 Multiple small solid nodules concerning for metastases                                                                                        Metastatic Epithelioid Hemangioendothelioma
  20                 1.4                                               1.5 0.1 cm invasive component               Left upper lobe      Prior right lung cancer IIIA                                                         Ground glass nodule                                                                                                                           Minimally Invasive Lung Adenocarcinoma pT1aN0
  21                 1.3                                               1.4 0.4 cm invasive component               Left upper lobe      Lung screening scan                                                                  Part solid ground glass opacity in                                                                                                            Minimally Invasive Lung Adenocarcinoma pT1aN0
  23                 0.8                                               0.8                                         Left upper lobe      Prior right upper lobe lung cancer                                                   Part solid lesion in could represent metastases or new primary lung                                                                           Metastatic Lung Squamous Cell Carcinoma
  24                 1.3                                               1.0                                         Right upper lobe     Screening CT                                                                         Multiple ground glass opacities could represent adenocarcinoma in situ                                                                        Lung Adenocarcinoma (in situ)
  25                 0.8                                               1.1 0.4 cm invasive component               Left upper lobe      16 pack year smoking                                                                 Part solid lesion could represent MIA                                                                                                         Minimally Invasive Lung Adenocarcinoma pT1aN0

© 2015 Wiley Periodicals, Inc.

All wedge resections were completed without intra‐operative complications. There were no operative or postoperative mortalities. The median length of hospital stay was 4 (range 2--12) days. Three patients had postoperative complications: pneumonia (in one patient who underwent lobectomy); prolonged air leak (1); and postoperative ileus (1). There were no requirements for ICU care, intubation, or any other invasive support. All complications were appropriately treated and resolved by the time of discharge from the hospital.

DISCUSSION {#jso23941-sec-0014}
==========

We describe herein a new image‐guided surgery workflow for intra‐operative marker‐guided thoracoscopic wedge resection that may be used to improve the precision of identifying and resecting small pulmonary nodules.. This approach can result in five potential benefits: (1) successful resection of early lung cancer with optimal margins and minimal resection of normal lung parenchyma, preserving lung function and allowing for future surgical therapies for second primary lung cancers; (2) a less invasive surgery without insertion of the hand or fingers into the chest to palpate for the nodule, potentially resulting in reduction in postoperative pain and time for recovery for the patient; (3) decreased total operative times and shorter hospital stays, and thus a more cost effective approach; (4) utilization of a single anesthetic for the marking and resection; and (5) shift of the treatment paradigm towards resection of more early‐stage tumors with a potential improvement in lung cancer ‐specific mortality rates.

Screening for lung cancer in at‐risk patients can lead to a reduction in cancer‐specific mortality [13](#jso23941-bib-0013){ref-type="ref"}, [14](#jso23941-bib-0014){ref-type="ref"}. It is estimated that with the implementation of lung cancer screening, indeterminate nodules will be detected in 8% to 51% of the patients screened [13](#jso23941-bib-0013){ref-type="ref"}, [15](#jso23941-bib-0015){ref-type="ref"}, and will need innovative surgical approaches for lung sparing surgery. Recent studies have demonstrated that sublobar resections, including segmentectomies and wedge resections, have comparable 5‐year survival rates to lobectomy for malignant small pulmonary nodules [16](#jso23941-bib-0016){ref-type="ref"}, [17](#jso23941-bib-0017){ref-type="ref"}. Smaller lung nodule size is associated with improved curative resection rates in lung cancer, without nodal disease [14](#jso23941-bib-0014){ref-type="ref"}. There is currently an on‐going prospective randomized phase III clinical trial through the Alliance Cooperative Group to compare the outcomes of patients undergoing lobectomy versus sublobar resections for \<2 cm stage I lung cancers, highlighting the current equipoise in the thoracic surgical community for alternative procedures in this patient cohort.

VATS resection is preferred to open surgery because of the use of smaller incisions and optimized postoperative recovery, including a shorter length of hospitalization [18](#jso23941-bib-0018){ref-type="ref"}. Studies have shown decreased operative and post‐operative morbidity with decreased operative times [19](#jso23941-bib-0019){ref-type="ref"}. However, in VATS wedge resection for small nodules, adequate identification of the target nodule has been be difficult, and a more significant resection or conversion to thoracotomy is occasionally needed to ensure complete resection. The current clinical trial demonstrated that intra‐operative image‐guided marking can be safely performed to effectively localize small pulmonary nodules for thoracoscopic wedge resection.

Since the 1990s a variety of methods have been proposed and described to mark lung nodules for easier identification of small nodules and help guide resection [20](#jso23941-bib-0020){ref-type="ref"}, [21](#jso23941-bib-0021){ref-type="ref"}. These ranged from percutaneous image guided injection of a dye (methylene blue) or radio‐opaque material such as barium sulphate, to percutaneously placed hookwires and micro‐coils in the radiology suite prior to surgery. The dye was generally injected under CT guidance adjacent to the nodule and was visualized by direct inspection during surgery or with fluoroscopy, as in the case of barium. The hookwires were placed adjacent to the lesion with the distal tip extending through the pleura and were secured to the skin surface. They have been found to improve lesion localization but have a tendency to dislodge during transportation to the operating room. The microcoils were similar, except that the distal end was deployed to extend along the pleural surface; the deployment is more complicated and requires interventional expertise [22](#jso23941-bib-0022){ref-type="ref"}. The novelty of our approach lies in the performance of this marking in real‐time, in the same suite, and proceeding immediately to resection in a hybrid operating room.

Hybrid operating rooms provide a suite using multimodality imaging with integrated hardware and software capable of 3D modeling and real time image‐ guidance for interventional and surgical procedures [23](#jso23941-bib-0023){ref-type="ref"}, [24](#jso23941-bib-0024){ref-type="ref"}. The wide availability of hybrid operating rooms, with over 1,000 reportedly in use in the US and in many other countries (originally for cardiac and vascular procedures), facilitates the rapid adoption of this approach. Many of these operating rooms are equipped with a C‐arm CT scanner that, with appropriate software, allows for excellent imaging of the lungs. Many such existing rooms were expensive to build and are under‐utilized, yet carefully planned iterations with experienced technological support from equipment and imaging vendors along with involvement of a dedicated and committed team can lead to improved utilization, and can pave the way for innovative minimally invasive thoracic procedures as described in our approach.

Unlike other protocols that utilize preoperative image‐guidance and dye or fiducial marking for nodule localization [20](#jso23941-bib-0020){ref-type="ref"}, [21](#jso23941-bib-0021){ref-type="ref"}, [22](#jso23941-bib-0022){ref-type="ref"}, intra‐operative nodule localization avoids the potential complications of placing markers in one procedure room and transferring the patient to another room for resection, minimizing respiratory motion, eliminating potential disruptions from anesthetic induction, airway instrumentation, and patient repositioning. The potential for marker dislodgement, bleeding, and pneumothoraces that can result from dislodgement are thus avoided. Even in the cases where the T‐bars were dislodged, the insertion points on the lung\'s surface, combined with intraoperative imaging, guided accurate resection. The logistics and costs of arranging two procedures in separate rooms are also mitigated.

The majority of the lesions resected in our protocol were primary lung cancers; seven of these were minimally invasive adenocarcinomas (MIA) and one adenocarcinoma in situ. All lesions were partially solid or mixed ground glass in attenuation with a small solid component, and all demonstrated growth leading to referral for surgery. Overall tumor size and the invasive component in the MIA lesions have been associated with improved overall survival rates. In fact, lymph nodeinvolvement is not usually seen in MIA lesions, even with sizes of up to 3 cm, which should further contribute to improved disease‐free survival [25](#jso23941-bib-0025){ref-type="ref"}, [26](#jso23941-bib-0026){ref-type="ref"}. However, due to the part ially solid nature of these lesions, it is often difficult to get a reliable diagnosis by image guided biopsies, and surgical resection may be difficult due to inability to palpate during surgery. Hence, historically these lesions were longitudinally followed until deemed resectable. With the implementation of Lung Cancer screening programs, a significant increase in the number of such nodules is anticipated; therefore downstream management pathways are needed. Our novel approach allows not only for targeted complete resection of small cancerous nodules but can ensure an optimal resection margin with lung sparing surgery [27](#jso23941-bib-0027){ref-type="ref"}, [28](#jso23941-bib-0028){ref-type="ref"}.

The intra‐operative imaging was optimized to minimize radiation exposure. With the exception of the first two cases, we estimated the radiation exposure in this trial ranged from 2.2 to 8.8 mSv, with a median of 3.5 mSv. The 36.5 and 17.5 mSv exposures are outliers, recorded during the first two cases when the preoperative planning involved an additional C‐arm CT scan for confirmation of the two T‐bars prior to VATS resection. For all subsequent cases only one intra‐operative C‐arm CT scan was acquired for lesion localization and fiducial placement using a lower dose acquisition protocol, with additional collimation. This allowed optimization of radiation exposure, which is in the range of a low dose lung cancer screening CT scan.

For perspective, the average annual exposure from natural sources is 3.1 mSv and this does not include the additional radiation exposure from medical and industry activities [29](#jso23941-bib-0029){ref-type="ref"}, [30](#jso23941-bib-0030){ref-type="ref"}. The total effective dose for each patient was estimated by adding the dose from fluoroscopy and the C‐arm CT scan. The effective dose attributed to fluoroscopy was estimated using a dose conversion coefficient of 0.12 mSv\*(Gy\*cm^2^)^−1^ for the fluoroscopy KAP [31](#jso23941-bib-0031){ref-type="ref"}. The effective dose from the C‐arm CT acquisition was estimated using a factory measured and weighted computed tomography dose index of 7.7 mGy/100 milliamperes and the k‐factor for chest scans of 0.017 mSv/(mGy\*cm).

The postoperative complication‐rates that occurred in this trial are comparable to those from standard VATS [32](#jso23941-bib-0032){ref-type="ref"}.

In conclusion, we described a new multimodality approach for image‐guided localization with immediate marker‐guided thoracoscopic wedge resection of small pulmonary nodules suspicious for early stage lung cancer in a hybrid OR setting. This approach is feasible, safe and efficacious with successful resection of all nodules, especially subcentimeter size or ground glass opacities.
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